|
The global healthcare company Grifols, based in Barcelona, Spain, is a world leader in plasma therapies. Grifols opened its first academy in the U.S. on January 28, 2009 in Glendale, Arizona. The academy, an 8,500 square foot facility, is adjacent to a fully operational plasma donor facility, and will serve as the company's central location for advanced employee education, training and career development.
The academy is equipped with advanced technology classrooms and an interactive learning laboratory. In addition, the academy houses two large conference rooms and an on-site gallery that showcases the history and importance of plasmapheresis in healthcare. According to the Academic Review Board that chairs the facility, the students will benefit from learning not only in their daily work, but also in their long-term personal and career development.
Academy Chairman, Eduardo Herrero said the company’s goal is to “provide our already highly skilled employees with an even broader context and deeper understanding of human health, ethics and science, as they relate to plasmapheresis."
Plasmapheresis is the process for obtaining human plasma that was developed by Grifols in 1951. It led to successful plasma therapies that have improved the life of hundreds of thousands of individuals with rare and often life-threatening diseases and conditions.
|
